ProMIS Neurosciences Inc PMN

Buzz on the Bullboards: The energy surge emanating from Trump’s 1st week in office

[Jonathon Brown]

The past week has seen a mixed performance for the TSX, reflecting the varied fortunes of different market sectors. While energy stocks experienced fluctuations, other sectors showed resilience,... read article.

[M101]

I had a problem with their science presentation independent from the eventual fraud, the core hypothesis* was never fleshed out on the website as it is with Promis.    *"Simufilam

[MikeTester]

https://beyondspx.com/article/promis-neurosciences-nasdaq-pmn-pioneering-antibody-therapeutics-targeting-toxic-misfolded-proteins-in-neurodegenerative-diseases

[FarmerBetsy]

The drama continues after the stock tanking is the class action law suit. Acoording to the complaint, defendants provided investors and materila information concerning Cassava's leading drug

[M101]

Sage is a Boston are pharma with a CNS focused drug platform including a couple of approved depression drugs. They were in a development agreement with Biogen which is about to end, and now

[G1945V]

M101, can you please connect the dots so I know if and how this saga (between Biogen and Sage) may or may not relate to PMN if this is where you are going?  G1945V

[M101]

I would love to know what our major investors are thinking about Sage suing Biogen today (I don't have the details). Is this why they want total control or are they already acting on behalf of

[Gbathat]

I just keep buying at these prices.  Hoping to get to 20K shares before the big news.  That will either be a great or terrible day, lol.  Nothing I can't afford to lose, but it sure

[Blueknowser1]

LOL. I actually was surprised to see the price go down after such a positive press release. I think we'll be rewarded within a few months, when the initial testing filters out.....! What I don'

[goldtech]

If Promis can show any efficacy in their 6 month interim results then the tranche A warrants will be exercised at 2.15 a share, if not then it's disaster for us all. Now, if they show no brain

[FarmerBetsy]

Not going anywhere, will see share price much lower what do they have if they can't partner any of there programs?  Will see Aria E and Aria H, i think Lecanumab was just under 2% Aria E in

[Gbathat]

I think they are doing a good job with communications in general.  The share price will do what it does.   Rome wasn't built in a day.  Alzheimer's sure as hell won't

[Thenorth1990]

Fully agreed, we can all get excited for the science but if it's not reflected on the stock price at the right time, then there is no point. Especially for retail invetsors, for accredited

[goldtech]

There is one thing that this company has consistently not been able to overcome and that is it's ability to deliver news that the market wants to hear. Lots of hopes and promises but never any

[M101]

j&j takes out itci for 14 B, 106 m shares out, that's PMN in 5 years or less

[PressRelease]

CAMBRIDGE, Massachusetts, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as...read article.